Stone, Addison E.
Scheuermann, Sarah E. https://orcid.org/0000-0002-9899-997X
Haile, Colin N.
Cuny, Gregory D. https://orcid.org/0000-0002-3188-4748
Velasquez, Marcela Lopez
Linhuber, Joshua P.
Duddupudi, Anantha L. https://orcid.org/0000-0002-9570-7206
Vigliaturo, Jennifer R.
Pravetoni, Marco https://orcid.org/0000-0003-1036-0184
Kosten, Therese A.
Kosten, Thomas R. https://orcid.org/0000-0003-1505-555X
Norton, Elizabeth B. https://orcid.org/0000-0002-8426-3515
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI114697, R01AI114697, R01AI114697, R01AI114697, R01AI114697, R01AI114697)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Defense (W81-XWH-15-2-007, W81-XWH-15-2-007)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Article History
Received: 26 October 2020
Accepted: 22 March 2021
First Online: 13 May 2021
Competing interests
: E.B.N., T.R.K., G.D.C., and C.N.H. are the inventors of a patent application based on the findings of this study. M.P. is the inventor of patent applications disclosing making and using anti-fentanyl vaccines.